Katharina Holstein

1.6k total citations
68 papers, 916 citations indexed

About

Katharina Holstein is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Katharina Holstein has authored 68 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 29 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Katharina Holstein's work include Hemophilia Treatment and Research (51 papers), Platelet Disorders and Treatments (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers). Katharina Holstein is often cited by papers focused on Hemophilia Treatment and Research (51 papers), Platelet Disorders and Treatments (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers). Katharina Holstein collaborates with scholars based in Germany, Austria and Italy. Katharina Holstein's co-authors include Robert Klamroth, Lize F. D. van Vulpen, Carlo Martinoli, Florian Länger, Carsten Bokemeyer, Andreas Tiede, Paul Knöbl, Michael Richards, Brigitte Spath and Hermann Eichler and has published in prestigious journals such as Blood, Endocrinology and Thrombosis and Haemostasis.

In The Last Decade

Katharina Holstein

60 papers receiving 900 citations

Peers

Countries citing papers authored by Katharina Holstein

Since Specialization

Citations

This map shows the geographic impact of Katharina Holstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Holstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Holstein more than expected).

Fields of papers citing papers by Katharina Holstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Holstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Holstein. The network helps show where Katharina Holstein may publish in the future.

Co-authorship network of co-authors of Katharina Holstein

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Holstein. A scholar is included among the top collaborators of Katharina Holstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Holstein. Katharina Holstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A 2025 ·Blood Advances ·(unknown), Christiane Dobbelstein, Robert Klamroth, Christina Hart, Ulrich J. Sachs, Richard Greil, Paul Knoebl, Johannes Oldenburg, Wolfgang Miesbach, Christian Pfrepper, Karolin Trautmann‐Grill, Patrick Möhnle, Katharina Holstein, Hermann Eichler, Sonja Werwitzke, Andreas Tiede	0
2	Detection of Anti-drug Antibodies in Patients with Acquired Hemophilia A: Data from the GTH-AHA-EMI Study 2025 ·Hämostaseologie ·(unknown), (unknown), Paul Knöbl, (unknown), (unknown), Johannes Oldenburg, Ulrich J. Sachs, (unknown), Karolin Trautmann‐Grill, Katharina Holstein, Hermann Eichler, Patrick Möhnle, (unknown), Robert Klamroth, Sonja Werwitzke, Andreas Tiede, (unknown)	1
3	Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study 2024 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Ulrich J. Sachs, Karolin Trautmann‐Grill, Christian Pfrepper, Paul Knöbl, Richard Greil, Johannes Oldenburg, Wolfgang Miesbach, Katharina Holstein, Hermann Eichler, Patrick Möhnle, (unknown), Christiane Dobbelstein, Robert Klamroth, Andreas Tiede	0
4	Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions 2024 ·Therapeutic Advances in Hematology ·Jan Blatný, (unknown), Cristina Catarino, G. Dolan, Karin Fijnvandraat, Cédric Hermans, Katharina Holstein, Víctor Jiménez‐Yuste, (unknown), Michelle Lavin, Peter J. Lenting, Sébastien Lobet, Maria Elisa Mancuso, (unknown), James S. O’Donnell, Christoph Königs	0
5	Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey 2024 ·Frontiers in Medicine ·(unknown), Georg Goldmann, Susan Halimeh, Katharina Holstein, Christoph Königs, Wolfgang Miesbach, Christian Pfrepper, Martin Olivieri	0
6	Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group 2023 ·Hämostaseologie ·Christian Pfrepper, Robert Klamroth, Johannes Oldenburg, Katharina Holstein, Hermann Eichler, Christina Hart, Patrick Moehnle, Kristina Schilling, Karolin Trautmann‐Grill, (unknown), Cihan Ay, Wolfgang Miesbach, Paul Knoebl, Andreas Tiede	10
7	Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer 2023 ·Hämostaseologie ·(unknown), Maximilian Lennartz, A Poch, Katharina Holstein, Carsten Bokemeyer, Florian Länger	1
8	Sixth Åland Island Conference on von Willebrand disease 2022 ·Haemophilia ·Erik Berntorp, Sonata Šaulytė Trakymienė, Augusto B. Federici, Katharina Holstein, Fernando F. Corrales‐Medina, Glenn F. Pierce, Alok Srivastava, M. von Depka Prondzinski, Jill M. Johnsen, Irena Zupan, Susan Halimeh, (unknown), Jonathan Roberts	4
9	Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia 2022 ·Thrombosis Research ·(unknown), Christina C. Rolling, Ulrich Budde, (unknown), Philippe Schafhausen, (unknown), Carsten Bokemeyer, Katharina Holstein, Florian Länger	4
10	The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B 2021 ·Haemophilia ·Jan Astermark, Katharina Holstein, (unknown), Susan Kearney, Stacy E. Croteau, (unknown), (unknown), Christine L. Kempton, Suchitra S. Acharya, Stefan Lethagen, Petra LeBeau, Joel Bowen, Erik Berntorp, Amy D. Shapiro	10
11	Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome 2021 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Minna Voigtlaender, Katharina Holstein, Maximilian Lennartz, Stefan W. Schneider, Munif Haddad, Thomas Renné, Carsten Bokemeyer, Christina C. Rolling, Florian Länger	2
12	Der Einfluss angeborener Blutungsneigungen auf den sozioökonomischen Status erwachsener Patient – Ergebnisse einer vergleichenden Single-Centre-Kohortenstudie 2017 ·Hämostaseologie ·Katharina Holstein, Sylvia von Mackensen, C. Bokemeyer, (unknown)	2
13	Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study 2017 ·Blood ·Katharina Holstein, (unknown), Paul Knöbl, Christiane Dobbelstein, Wolfgang Miesbach, Michael Spannagl, (unknown), Ute Scholz, Hermann Eichler, Angela Huth‐Kühne, Robert Klamroth, Armin Koch, Andreas Tiede	2
14	Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study 2016 ·Journal of Thrombosis and Haemostasis ·Sonja Werwitzke, Ulrich Geisen, Ulrike Nowak‐Göttl, Hermann Eichler, Brigitte Stephan, (unknown), Katharina Holstein, Robert Klamroth, Paul Knöbl, Angela Huth‐Kühne, (unknown), Andreas Tiede	42
15	Current view and outcome of ITI therapy - A change over time? 2016 ·Thrombosis Research ·Katharina Holstein, Angelika Bátorová, (unknown), Karin Fijnvandraat, Pål André Holme, Kaan Kavaklı, Thierry Lambert, Angiola Rocino, Víctor Jiménez‐Yuste, Jan Astermark	17
16	Erfolgreiche zweite Immuntoleranzinduktion mit Faktor IX und kombinierter Immunsuppression bei einem Patienten mit schwerer Hämophilie B und Inhibitor-Rezidiv 2014 ·Hämostaseologie ·Katharina Holstein, Reinhard Schneppenheim, Johanna Schrum, C. Bokemeyer, Florian Länger	1
17	Relationship between haemophilia and social status 2014 ·Thrombosis Research ·Katharina Holstein, Barbara Eifrig, Florian Länger	12
18	Thrombin generation in a patient with an acquired high-titre factor V inhibitor 2014 ·Blood Coagulation & Fibrinolysis ·David E. Schmidt, (unknown), Claudia Schnabel, Brigitte Spath, Katharina Holstein, Walter Fiedler, Carsten Bokemeyer, Thomas Renné, Florian Länger	3
19	Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus 2014 ·Experimental Hematology and Oncology ·Christina Dicke, Katharina Holstein, Sonja Schneppenheim, Rita Dittmer, Reinhard Schneppenheim, Carsten Bokemeyer, Christof Iking‐Konert, Ulrich Budde, Florian Länger	12
20	Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation 2008 ·Annals of Hematology ·Florian Länger, Brigitte Spath, (unknown), Katharina Holstein, (unknown), Jan Wierecky, Tim H. Brümmendorf, Judith Dierlamm, Carsten Bokemeyer, Barbara Eifrig	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact